Germany· DE-A57-4e8c7393cc729e43
Bupivacain Mit Epinephrin Jenapharm
A medicinal product containing bupivacaine hydrochloride, adrenaline hydrogen tartrate, registered in Germany by Mibe Gmbh Arzneimittel.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Bupivacaine Hydrochloride, Adrenaline Hydrogen Tartrate
- Manufacturer
- Mibe Gmbh Arzneimittel
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupivacaine hydrochloride, adrenaline hydrogen tartrate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayBupivacain mit Epinephrin jenapharmMibe
- SpainBUPIVACAÍNA/ADRENALINA PHYSAN 2,5 MG/ML + 0,005 MG/ML SOLUCIÓN INYECTABLELaphysan S.A.U.
- NetherlandsMarcaine 2,5 mg/ml + 5 microgram/ml adrenaline oplossing voor injectieAspen Pharma Trading Limited
- IcelandMarcain adrenalinAspen Pharma Trading Limited
- CanadaSENSORCAINE WITH EPINEPHRINEASPEN PHARMACARE CANADA INC.
- SwedenMarcain adrenalin 2,5 mg/ml + 5 mikrogram/ml Injektionsvätska, lösningAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Marcaine Adrenaline, Marcaine Adrénaline
- Denmark · Marcain
- Finland · Marcain
- Iceland · Marcain Adrenalin
- Italy · Bupisen Con Adrenalina
- Luxembourg · Marcaine Adrenaline, Marcaine Adrénaline
- Netherlands · Marcaine Adrenaline
- Norway · Marcain Adrenalin
- Poland · Marcaine -Adrenaline
- Sweden · Marcain Adrenalin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad754159-99fc-4ccb-8f6e-9fc037eac51c GET /v1/drugs/ad754159-99fc-4ccb-8f6e-9fc037eac51c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Epidural Use, Intradermal Use, Intrathecal Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Bupivacaine Hydrochloride, Adrenaline Hydrogen Tartrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about bupivacaine hydrochloride, adrenaline hydrogen tartrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.